FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Vaccine   Pfizer   Prevnar-13   Boostrix
Syndicate content

FDA approval News

Most Popular FDA approval Story

AstraZeneca's FluMist Quadrivalent to hit U.S. market

The FDA has approved AstraZeneca's ($AZN) nasal FluMist Quadrivalent flu vaccine for use in people ages 2 to 49. Made at AstraZeneca's MedImmune unit, FluMist Quadrivalent contains two Read more...

FDA approval Press Releases

  • Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
  • Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington, D.
  • Genzyme Announces FDA Approval of Framingham Manufacturing Plant
  • Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc.
  • AIBioTech LLC Assists EUSA Pharma in Obtaining FDA approval for a Critical Drug Product

Latest Headlines